ZBH
Zimmer Biomet Holdings Inc.
$100.56
+$1.00(+1.00%)
64
Overall
90
Value
60
Tech
44
Quality
Market Cap
$20.04B
Volume
2.12M
52W Range
$89.22 - $114.72
Target Price
$110.74
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $6.0B | $7.7B | $7.8B | $7.9B | $8.0B | $7.0B | $6.8B | $6.9B | $7.4B | $7.7B | ||
| Total Revenue | $6.0B | $7.7B | $7.8B | $7.9B | $8.0B | $6.1B | $6.8B | $6.9B | $7.4B | $7.7B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $1.8B | $2.4B | $2.1B | $2.3B | $2.4B | $1.8B | $2.0B | $2.0B | $2.1B | $2.2B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $3.4B | $4.7B | $5.2B | $5.4B | $5.6B | $4.3B | $4.9B | $4.9B | $5.3B | $5.5B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $2.9B | $3.9B | $4.1B | $4.4B | $4.4B | $4.1B | $3.8B | $3.7B | $3.9B | $4.0B | ||
| Research & Development | $268.8M | $365.6M | $369.9M | $391.7M | $449.3M | $372.0M | $435.8M | $406.0M | $458.7M | $437.4M | ||
| Research Expense | $268.8M | $365.6M | $369.9M | $391.7M | $449.3M | $372.0M | $435.8M | $406.0M | $458.7M | $437.4M | ||
| Selling, General & Administrative | $2.3B | $2.9B | $3.1B | $3.4B | $3.3B | $3.2B | $2.8B | $2.8B | $2.8B | $2.9B | ||
| Selling & Marketing Expenses | $2.3B | $2.9B | $3.1B | $3.4B | $3.3B | $3.2B | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-60.1M | $-74.0M | $-87.2M | $-72.2M | $-76.0M | $-83.7M | $2.8B | $2.8B | $2.8B | $2.9B | ||
| Salaries & Wages | $-46.4M | $-57.3M | $-53.7M | $-65.5M | $-84.3M | $-79.7M | $-18.7M | -- | -- | -- | ||
| Depreciation & Amortization | $337.4M | $565.9M | $603.9M | $595.9M | $584.3M | $597.6M | $529.5M | $526.8M | $561.5M | $591.9M | ||
| Depreciation & Amortization | $337.4M | $565.9M | $603.9M | $595.9M | $584.3M | $597.6M | $529.5M | $526.8M | $561.5M | $591.9M | ||
| Amortization | $337.4M | $565.9M | $603.9M | $595.9M | $584.3M | $597.6M | $529.5M | $526.8M | $561.5M | $591.9M | ||
| Other Operating Expenses | $-25.7M | $-53.0M | $-24.8M | $-41.9M | $-133.2M | $-3.4M | $-7.3M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $467.3M | $825.9M | $1.1B | $1.0B | $1.2B | $557.2M | $860.3M | $696.3M | $1.3B | $1.3B | ||
| EBITDA | $945.1M | $1.4B | $1.2B | $486.6M | $1.9B | $1.0B | $1.6B | $1.5B | $2.2B | $2.3B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $286.6M | $357.9M | $327.5M | -- | $226.9M | $212.1M | $208.4M | $164.8M | $201.2M | $218.0M | ||
| Intinc | $9.4M | $2.9M | $2.2M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-277.2M | $-355.0M | $-325.3M | -- | $-226.9M | $-212.0M | $-208.4M | $-164.8M | $-201.2M | $-218.0M | ||
| Other Income/Expense | $36.9M | $71.3M | $9.4M | $15.6M | $4.8M | $-25.4M | $152.9M | $-623.8M | $9.3M | $31.1M | ||
| Other Special Charges | $-36.9M | $-71.3M | $-9.4M | $-15.6M | $-4.8M | $25.4M | $-152.9M | $-128.0M | $-9.3M | $-31.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-330.2M | $-90.7M | $-17.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | $330.2M | $13.0M | $-331.5M | $-979.7M | $-70.1M | $-645.0M | $-16.3M | $-292.8M | $-21.6M | $-30.5M | ||
| Impairment of Capital Assets | -- | $-13.0M | $331.5M | $979.7M | $70.1M | $645.0M | $16.3M | $292.8M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $232.7M | $394.4M | $147.1M | $-553.9M | $905.8M | $106.9M | $707.4M | $568.3M | $1.3B | $1.3B | ||
| Pre-Tax Income | $153.2M | $399.6M | $464.6M | $-271.1M | $905.8M | $-274.4M | $499.0M | $403.5M | $1.1B | $1.0B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $7.0M | $95.0M | $-1.3B | $108.2M | $-225.7M | $-96.0M | $53.5M | $112.3M | $42.2M | $131.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $147.0M | $305.9M | $1.8B | $-379.3M | $1.1B | $-138.9M | $401.6M | $231.4M | $1.0B | $903.8M | ||
| Net Income (Continuing Operations) | $147.0M | $305.9M | $1.8B | $-379.3M | $1.1B | $-138.9M | $401.6M | $291.2M | $1.0B | $905.3M | ||
| Net Income (Discontinued Operations) | $147.0M | $305.9M | $1.8B | $-379.3M | $1.1B | $-138.9M | $401.6M | $231.4M | $1.0B | $903.8M | ||
| Net Income (Common Stockholders) | $147.0M | $305.9M | $1.8B | $-379.2M | $1.1B | $-138.9M | $401.6M | $231.4M | $1.0B | $903.8M | ||
| Normalized Income | -- | -- | -- | -- | $750.2M | $233.6M | -- | -- | -- | $1.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $4.7B | $6.2B | $6.2B | $6.6B | $6.8B | $6.5B | $5.8B | $5.7B | $5.9B | $6.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $187.4M | $200.0M | $201.9M | $203.5M | $205.1M | $207.0M | $208.6M | $209.6M | $208.7M | $203.1M | ||
| Average Shares Outstanding (Diluted) | $189.8M | $202.4M | $203.7M | $203.5M | $206.7M | $207.0M | $210.4M | $210.3M | $209.7M | $203.9M | ||
| Shares Outstanding | $198.8M | $201.1M | $203.1M | $204.4M | $206.4M | $207.9M | $209.2M | $209.0M | $205.1M | $199.1M | ||
| Basic EPS | $0.78 | $1.53 | $8.98 | $-1.86 | $5.52 | $-0.67 | $1.93 | $1.1 | $4.91 | $4.45 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $5.52 | $-0.67 | $1.93 | $1.38 | $4.91 | $4.45 | ||
| Diluted EPS | $0.77 | $1.51 | $8.9 | $-1.86 | $5.47 | $-0.67 | $1.91 | $1.1 | $4.88 | $4.43 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $5.47 | $-0.67 | $1.91 | $1.38 | $4.88 | $4.43 | ||
| Dividend Per Share | $0.88 | $0.96 | $0.96 | $0.96 | $0.96 | -- | $0.96 | -- | $0.96 | $0.96 | ||
| OTHER METRICS | ||||||||||||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | $-0.28 | -- | -- | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | $-0.28 | -- | -- | ||
| Gain On Sale Of P P E | $19.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-207.1M | $-363.1M | $-317.5M | $-282.8M | $-226.9M | $-193.1M | -- | -- | -- | -- | ||
| Minority Interests | $800.0K | $1.3M | $400.0K | $100.0K | $100.0K | $-1.5M | $-500.0K | $-1.0M | $-1.1M | $-1.5M | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | -- | -- | $37.2M | -- | -- | -- | ||
| Net Operating Interest Income Expense | -- | -- | $-325.3M | $-289.3M | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | $-15.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | -- | -- | $1.0B | -- | -- | -- | ||
| Other Gand A | $-60.1M | $-74.0M | $-87.2M | $-72.2M | $-76.0M | $-83.7M | $2.8B | $2.8B | $2.8B | $2.9B | ||
| Other Impairment Of Capital Assets | $-3.8M | $-30.0M | $-26.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-60.1M | $-74.0M | $-87.2M | $-72.2M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $2.3B | $2.9B | $3.1B | $3.4B | $3.3B | $3.2B | -- | -- | -- | -- | ||
| Restruct | $-330.2M | $-90.7M | $-17.3M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZBH | $100.56 | +1.0% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zimmer Biomet Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW